A Critique of SAINT II
Authors:
- 1 April 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 39 (4) , 1389-1391
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- NXY-059 for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 2007
- A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: A need for more rigorous testing of neuroprotective agents in animal models of strokeExperimental Neurology, 2007
- Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I TrialStroke, 2006
- Toward a Multimodal Neuroprotective Treatment of StrokeStroke, 2006
- NXY-059 for Acute Ischemic StrokeNew England Journal of Medicine, 2006
- Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trialThe Lancet, 2004
- Functional and Histological Evidence for the Protective Effect of NXY-059 in a Primate Model of Stroke When Given 4 Hours After OcclusionStroke, 2003
- Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N -Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke ModelStroke, 2002
- Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time windowBritish Journal of Pharmacology, 2002
- Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1999